Table 4: Proportions of patients who filled prescriptions for secondary prevention therapy within 1 year after primary intracerebral hemorrhagic stroke by ethnicity
MedicationEthnicity; no. (%) of patientsp value
Chinese
n = 546
Other Canadians
n = 8917
South Asian
n = 200
ACE inhibitor200 (36.6)3924 (44.0)118 (59.0)< 0.001
Angiotensin-receptor blocker80 (14.6)827 (9.3)23 (11.5)0.001
ACE inhibitor or angiotensin-receptor blocker252 (46.2)4428 (49.6)127 (63.5)0.001
Diuretic109 (20.0)2845 (31.9)57 (28.5)< 0.001
Calcium-channel blocker185 (33.9)2716 (30.4)63 (31.5)0.2
β-blocker139 (25.4)2682 (30.1)64 (32.0)0.1
ACE inhibitor or diuretic253 (46.3)4942 (55.4)131 (65.5)< 0.001
ACE inhibitor + diuretic56 (10.2)1827 (20.5)44 (22.0)< 0.001
Any antihypertensive352 (64.5)6125 (68.7)155 (77.5)0.003

Note: ACE = angiotensin-converting-enzyme.